共 41 条
- [1] Surveillance, Epidemiology, and End Results (SEER) Cancer Stat Facts: Pancreatic Cancer, (2021)
- [2] Siegel R.L., Miller K.D., Jemal A., Cancer statistics, CA Cancer J. Clinicians, 2020, 70, pp. 7-30, (2020)
- [3] Preoperative staging, and evaluation of resectability in pancreatic ductal adenocarcinoma, HPB (Oxford), 2004, 6, pp. 5-12, (2004)
- [4] Mizrahi Jonathan D, Surana Rishi, Valle Juan W, Shroff Rachna T, Pancreatic cancer, The Lancet, 395, pp. 2008-2020, (2020)
- [5] The ambiguous role of the inflammatory micromilieu in solid tumors, Pathology, 41, pp. 118-123, (2020)
- [6] Mayer P., Dinkic C., Jesenofsky R., Klauss M., Schirmacher P., Dapunt U., Hackert T., Uhle F., Hansch G.M., Gaida M.M., Changes in the microarchitecture of the pancreatic cancer stroma are linked to neutrophil-dependent reprogramming of stellate cells and reflected by diffusion-weighted magnetic resonance imaging, Theranostics, 8, pp. 13-30, (2018)
- [7] Grosse-Steffen T., Giese T., Giese N., Longerich T., Schirmacher P., Hansch G.M., Gaida M.M., Epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma and pancreatic tumor cell lines: The role of neutrophils and neutrophil-derived elastase, Clinical and Developmental Immunology, pp. 1-12, (2012)
- [8] Gaida M.M., Steffen T.G., Gunther F., Tschaharganeh D.F., Felix K., Bergmann F., Schirmacher P., Hansch G.M., Polymer-photonuclear neutrophils promote dyshesion of tumor cells and elastase-mediated degradation of E-cadherin in pancreatic tumors, Eur. J. Immunol, 42, pp. 3369-3380, (2012)
- [9] Verbeke C., Morphological heterogeneity in ductal adenocarcinoma of the pancreas—Does it matter?, Pancreatology, 16, pp. 295-301, (2016)
- [10] Hruban R.H., Adsay N.V., Albores-Saavedra J., Compton C., Garrett E.S., Goodman S.N., Kern S.E., Klimstra D.S., Kloppel G., Longnecker D.S., Pancreatic intraepithelial neoplasia: (A new nomenclature and classification system for pancreatic duct lesions), Am. J. Surg. Pathol, 25, pp. 579-586, (2001)